Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study

2 mins read

The FINANCIAL — Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, on October 7 announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.

The IDEAS Study will assess the clinical usefulness and value in using an amyloid brain positron emission tomography (PET) scan in certain situations when evaluating Alzheimer’s disease (AD) and other dementias.  Amyvid (Florbetapir F-18 Injection), Lilly’s FDA-approved radioactive PET diagnostic agent for the estimation of beta-amyloid neuritic plaque density in the brain, will be one diagnostic agent available for use in the study.  It is important to note that a positive Amyvid scan does not establish a diagnosis of AD or other cognitive disorder, according to Lilly.

Manufactured in and distributed from 30 radiopharmacy facilities throughout the United States, Amyvid is currently supplied to a robust network of PET imaging sites by Siemens’ PETNET Solutions and Cardinal Health. Amyvid for intravenous use is supplied in 10 mL, 30 mL, or 50 mL multidose vials containing 500-1900 MBq/mL Florbetapir F-18.

“Lilly is pleased to support and participate in this important study,” said David Ricks, Lilly Senior Vice President and President of Lilly Bio-Medicines. “Alzheimer’s disease is one of the most devastating diseases of our time, and we are committed to ensuring that patients and physicians have appropriate and reliable access to this adjunctive diagnostic tool.” 

Mark Mintun, MD, President of Avid Radiopharmaceuticals represents Lilly on the IDEAS Study Steering Committee. “We hope this study will add important new data to a growing body of evidence demonstrating the value beta-amyloid imaging may bring to patients with cognitive impairment being evaluated for Alzheimer’s disease and other causes of cognitive decline,” explained Mintun.

 

Leave a Reply